Cargando…
Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
Myasthenia gravis is a chronic autoimmune disease characterized by autoantibody-mediated interference of signal transmission across the neuromuscular junction. We performed a genome-wide association study (GWAS) involving 1,873 patients diagnosed with acetylcholine receptor antibody-positive myasthe...
Autores principales: | Chia, Ruth, Saez-Atienzar, Sara, Murphy, Natalie, Chiò, Adriano, Blauwendraat, Cornelis, Roda, Ricardo H., Tienari, Pentti J., Kaminski, Henry J., Ricciardi, Roberta, Guida, Melania, De Rosa, Anna, Petrucci, Loredana, Evoli, Amelia, Provenzano, Carlo, Drachman, Daniel B., Traynor, Bryan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812681/ https://www.ncbi.nlm.nih.gov/pubmed/35074870 http://dx.doi.org/10.1073/pnas.2108672119 |
Ejemplares similares
-
Reply to Zhu et al.: Implications of CHRNB1 and ERBB2 in the pathobiology of myasthenia gravis
por: Chia, Ruth, et al.
Publicado: (2022) -
Controversies in Ocular Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2020) -
Thymoma‐associated myasthenia gravis: Clinical features and predictive value of antiacetylcholine receptor antibodies in the risk of recurrence of thymoma
por: De Rosa, Anna, et al.
Publicado: (2020) -
Editorial: News and Views in the Management of Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2021) -
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients
por: Basile, Umberto, et al.
Publicado: (2018)